Relmada Therapeutics, Inc.

Q2 2020 13F Holders

Symbol
RLMD
CUSIP
75955J402
Type
Equity
Class
COM
Num filings
84
Total reported value, excl. options
$469 M
Manager Report Date Value ($000) Shares Option Type